NEW BRUNSWICK, N.J., March 14 /PRNewswire/ -- The 10th Anniversary Inflammation & Immune Diseases Drug Discovery & Development Summit, considered to be the best-attended & longest running meeting for the pharmaceutical and biotechnology inflammation communities, will convene on March 20-21, 2006 in New Brunswick, NJ. The 2006 meeting brings together the world industrial community of over 150 immunology & inflammatory researchers for their annual review on their programs intended to generate next generation drugs, announces Strategic Research Institute.
The agenda offers the latest clinical updates on Daxas(R) (roflumilast), PI3K for RA, LFA-1 Inhibition, H4 Receptors for Allergy, Src-family Lck Inhibitors, TLR Novel Targets for Autoimmunity, and many more. The following highlighted keynotes are listed in detail below:
To B or not to B: Targeting of Activation Induced Cytidine Deaminase as a Novel B Cell Therapy for Autoimmune Disease and Arthritis John Mountz, M.D., Ph.D. Professor, Department of Medicine Division of Clinical Immunology & Rheumatology UNIVERSITY OF ALABAMA BIRMINGHAM Role of Eukaryotic Translation Initiation factor 5A in Acute Lung Injury Charles Dinarello Professor of Medicine UNIVERSITY OF COLORADO HEALTH SCIENCES CENTER Complete and updated list of presenting companies and institutions includes: * 3M Pharmaceuticals * Corgentech, Inc. * Abbott Laboratories * Cytimmune Sciences, Inc. * Altana Pharma US * Elan Pharmaceuticals * Altana Pharma AG * EntreMed, Inc. * Amira Pharmaceuticals * Hoffman-La Roche * AstraZeneca * IsisPharmaceuticals * AstraZeneca R&D Charnwood, UK * Isogenis, Inc. * Atherogenics, Inc. * Johnson & Johnson Pharmaceutical R&D * Biogen Idec * MD Biosciences * Celgene Corporation * MedImmune * Celgene San Diego * Merck Research Laboratories * National Institute of Standards & Technology * Novartis Pharma * Novosom AG * Pliva Research Institute Ltd. * Sangamo Biosciences * Serono Pharmaceutical Research Institute * Ben-Gurion University Medical Center * Texas Tech University Health Sciences Center * University of Alabama Birmingham * University of Colorado * University of Copenhagen, Denmark
To register for the event, please visit www.srinstitute.com/IIDS. THE LAST DAY TO PRE-REGISTER FOR THE CONFERENCE IS FRIDAY, MARCH 17.
To receive the full agenda in PDF, please contact Ed Drilon of Strategic Research Institute at edrilon@srinstitute.com or 212-967-0095, x233 (please include name and corporate affiliation).
Leverage our strong position in the industrial inflammatory and immune diseases area to showcase your products and services to this high-level, targeted audience of pharmaceutical scientists and executive decision makers. To inquire about sponsorship & exhibition opportunities, please contact Ed Drilon at 212-967-0095 x233, edrilon@srinstitute.com. LUNCHEON AND RECEPTION SPEAKING OPPORTUNITIES FOR BOTH DAYS REMAIN AVAILABLE.
Strategic Research InstituteCONTACT: Ed Drilon of Strategic Research Institute, +1-212-967-0095, ext.233, or edrilon@srinstitute.com
Web site: http://www.srinstitute.com//
